This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

WILLIAM M. FITZHUGH, JR., M.D.

Arch Otolaryngol. 1936;24(4):425-435.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

It is the purpose of this paper to introduce to the otolaryngologist neosynephrin hydrochloride, a new vasoconstrictor which some pharmacologists believe to be superior to epinephrine and ephedrine for local intranasal application. Neosynephrin hydrochloride was accepted by the Council on Pharmacy and Chemistry of the American Medical Association about two years ago and is described in "New and Nonofficial Remedies," yet many otolaryngologists are not familiar with its biologic properties because investigators have reported their experimental and clinical results only in pharmacologic journals.

In order to make this paper complete I wish to give, first, a brief résumé of the chemistry of the drug and its relationship to other popular vasoconstrictors; second, a review of the previous biologic investigations and a report of the experiments on local intranasal application carried out for purposes of confirmation, and, finally, a résumé of fifteen cases, with a summary of . . . [Full Text PDF of this Article]

Author Affiliations
PHILADELPHIA

Footnotes
Thesis submitted in partial fulfilment of the requirements for the M.Sc. (Med.) degree in otolaryngology, Graduate School of Medicine, University of Pennsylvania.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?